Antisecretory factor suppresses intestinal inflammation and hypersecretion

Gut

Volumn 41, Issue 5, 1997, Pages

  Johansson, E ^a   Jennische, E ^a   Lange, S ^b   Lonnroth I ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b Department of Clinical Bacteriology ^*

Author keywords

Clostridium difficile toxin A; Diarrhoea; Neuropeptide; Okadaic acid; Rat; S5a

Indexed keywords

ANTISECRETORY FACTOR; CLOSTRIDIUM TOXIN; OKADAIC ACID; RECOMBINANT PROTEIN; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CLOSTRIDIUM DIFFICILE; CONTROLLED STUDY; ENTERITIS; GOBLET CELL; INTESTINE FLUID; INTESTINE SECRETION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 20644451195     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.41.5.642     Document Type: Article

References (12)

1. Bartlett JG. Clostridium difficile: history of its role as an enteric pathogen and the current state of knowledge about the organism. Clin Infect Dis 1994; 18 (suppl 4): S265-72.
2. Lyerly DM, Saum KE, MacDonald DK, Wilkins TD. Effects of Clostridium difficile toxins given intragastrically to animals. Infect Immun 1985; 47: 349-52.
3. Torres J, Jennische E, Lange S, Lönnroth I. Enterotoxins from Clostridium difficile; diarrhoeogenic potency and morphological effects in the rat intestine. Gut 1990; 31: 781-5.
4. Krivan HC, Clark GF, Smith DF, Wilkins TD. Cell surface binding site for Clostridium difficile enterotoxin: evidence for a glycoconjugate containing the sequence Gala1-3Galb1-4GlcNAc. Infect Immun 1986; 53: 573-81.
5. Teneberg S, Lönnroth I, Torres JF, Galili U, Ölvegård-Halvarsson M, Ångström J, Karlsson KA. Molecular mimicry in the recognition of glycosphingolipids by Gal alpha 3 Gal beta 4GlcNAc beta-binding Clostridium difficile toxin A, human natural anti α-galactosyl IgG and the monoclonal antibody Gal-13: characterization of a binding-active human glycosphingolipid non-identical with the animal receptor. Glycobiology 1996; 6: 599-609.
6. Just I, Wilm M, Selzer J, Rex G, Von Eichel-Streiber C, Mann M, Aktories K. The enterotoxin from C. difficile (ToxA) monoglycosylates the Rho proteins. J Biol Chem 1995; 270: 13932-6.
7. Von Eichel-Streiber C, Boquet P, Sauerborn M, Thelestam M. Large clostridial cytotoxins - a family of glycosyltransferases modifying small GTP-binding proteins. Trends Microbiol 1996; 4: 375-82.
8. Castagliuolo I, LaMont JT, Letourneau R, Kelly CP, O'Keane JC, Jaffer A, et al. Neuronal involvment in the intestinal effects of Clostridium difficile toxin A and Vibrio cholerae enterotoxin in rat ileum. Gastroenterology 1994; 107: 657-65.
9. Qui B, Pothoulakis C, Castagliuolo I, Nikulasson Z, LaMont JT. Nitric oxide inhibits rat intestinal secretion by Clostridium difficile toxin A but not Vibrio cholerae enterotoxin. Gastroenterology 1996; 111: 409-18.
10. Yasumoto T, Oshima Y, Yamagushi M. Occurence of a new type of shellfish poisoning in the Tohoku district. Bull Jpn Soc Sci Fish 1978; 44: 1249-55.
11. Yasumoto T, Murata M, Oshima Y, Matsumoto GK, Clardy J. Diarrhetic shellfish toxins. Tetrahedron 1985; 41: 1019-25.
12. Edebo L, Lange S, Li XP, Allenmark S. Toxic mussels and okadaic acid induce rapid hypersecretion in the rat small intestine. APMIS 1988; 96: 1029-5.